Q-Med Pays To Shut Down Genzyme Injection IP Fight
Medical device manufacturer Q-Med AB has settled Genzyme Corp.'s patent infringement suit over a group of cosmetic injection products licensed to Medicis Pharmaceutical Corp., agreeing to make a lump sum payment...To view the full article, register now.
Already a subscriber? Click here to view full article